Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-503-2 | CAS number: 96-37-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
No studies are available for the registered substance Methylcyclopentane. Based on the read across approach, information om the structural analogue n-Hexane is used.
Three in vitro genetic toxicity studies were read across based on data for commercial hexane (52% n-hexane).
All in vitro genetic toxicity tests were negative.
Genetic Toxicity in vitro - Bacterial reverse mutation assay (OECD TG 471) - Negative
Genetic Toxicity in vitro - In vitro Mammalian Chromosome Aberration Test (OECD TG 473) - Negative
Genetic Toxicity in vitro - In vitro Mammalian Cell Gene Mutation Test (OECD TG 476) - Negative
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-05-19 to 1989-07-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restrictions because it is well documented and follows OECD Guideline 471.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- The method was modified to use the dessicator methodology in order to test the mutagenicity of the vapor phase of the test substance.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium, other: TA 1535, TA 1537, TA 1538, TA 98, TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from aroclor induced rat liver
- Test concentrations with justification for top dose:
- 0, 600, 1000, 3000, 6000, 9000 ppm
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- other: no solvent used
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene, 2-nitrofluorene, sodium azide, 9-aminoacridine, 1,1-dichloroethene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Prepared plates were placed uncovered and inverted in 9l dessicators. An appropriate amount of test substance was placed in a glass petri dish was suspended at the bottom of the dessicator. A magnetic stirring bar was placed at the bottom of the dessicator, and served as a fan to ensure even distribution of the vapor.
DURATION
- Preincubation period: 48 hrs
- Exposure duration: 7-8 hrs at 37 degree C
- Expression time (cells in growth medium): There was an additional incubation time of 40 hrs after exposure.
NUMBER OF REPLICATIONS: 3
- Evaluation criteria:
- To be considered positive for mutation, at least a doubling of mean revertants per plate in at least one tester strain must be seen. This increase must be dose-related.
- Statistics:
- Mean number of revertant per plate and the standard deviation was calculated.
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 1538, TA 98, TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No positive responses were observed in any of the tester strains. The positive control substance, 2-aminoanthracene, did not produce any mutations in strain TA 1538 in one experiment in the presence of S9. As revertants were seen in the test of TA 1538 without S9, and revertants were seen in other strains exposed to positive controls with S9, the lack of revertants was most likely due to a technical error and the study is still considered valid.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results: negative
The test substance is not mutagenic. - Executive summary:
This study examined the mutagenicity of vapors of the test substance commercial hexane. Plates of S. typhimurium were exposed for 7 -8 hrs to test atmospheres of 0, 600, 1000, 3000, 6000, or 9000 ppm of test substance. 20,000 ppm of 1,1 -dichloroethene was used a vapor-phase positive control substance.
The test substance did not produce a positive response in any of the test strains. The test substance is not mutagenic.
- Endpoint:
- genetic toxicity in vitro, other
- Remarks:
- bacteria, mammalian cells
- Type of information:
- other: data from collection of data
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix from livers of male rats or Syrian hamsters
- Test concentrations with justification for top dose:
- up to 1000 µg/plate
- Details on test system and experimental conditions:
- pre-incubation test
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Conclusions:
- No in vitro toxicity found in assays using bacterial cells.
- Executive summary:
No in vitro toxicity found in assays using bacterial cells.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-08-28 to 1990-04-02
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restrictions because it is well documented and follows OECD Guideline 476.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- Periodically checked for Mycoplasma contamination: yes- Additional strain / cell type characteristics:
- other: K1-BH4
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from aroclor induced rat liver
- Test concentrations with justification for top dose:
- 0, 0.132, 0.098, 0.063, 0.0362, 0.0122 ul/ml (analytical)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethylmethanesulphonate 0.2 ul/ml without metabolic activation, benzo(a)pyrene 4 ug/ml with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: 7.5 ml of test substance was added to 17.5 ml of DMSO and vortexed for 2 min. The solution was allowed to separate, and the bottom DMSO/test substance layer and diluted further with DMSO. Appropriate amounts were then added to the test medium.
DURATION
- Preincubation period: 18-24 hrs at 37 degree C
- Exposure duration: 5 hrs at 37 degree C
- Expression time (cells in growth medium): 18-24 at 37 degree C
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
Replicates from each treatment concentration were pooled and cultured in triplicate (100 cells/60 mm dish). After 7 days of incubation, colonies were fixed with methanol , stained with Giemsa, and counted. Determination was based on relative cloning efficiency. - Evaluation criteria:
- mutant frequency > 20 mutants per 10^6 clonable cells, at least twice the mutant frequency of negative and solvent controls, mutant frequency above negative and solvent controls of at least 11 mutants per 10^6 clonable cells
- Statistics:
- Students t-test (p <= 0.05)
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- None of the mutant frequencies in the test groups were significantly elevated over negative and solvent controls. The test substance was cytotoxic at concentrations of 0.063 ul/ml or greater.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results: negative
The test substance is not mutagenic. - Executive summary:
This study determined the mutagenicity of commercial hexane to Chinese hamster ovary (CHO) cells. CHO cells were exposed to concentrations of 0, 0.132, 0.098, 0.063, 0.0362, or 0.0122 µL/mL both with and without metabolic activation for 5 hrs. The cells were then analyzed for mutation frequency. A concurrent cytotoxicity assay was performed.
Results of the mutagenicity assay show that the test substance is not mutagenic both in the presence and absence of metabolic activation. However, the test substance was cytotoxic at concentrations of 0.063 µl/mL or greater.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-08-24 to 1990-02-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it followed a protocol comparable to OECD Guideline 473.
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Additional strain / cell type characteristics:
- other: CHO-K1 cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from aroclor induced rat liver
- Test concentrations with justification for top dose:
- 0.015, 0.034, 0.074, 0.123, 0.416 ul/ml without S9
0.014, 0.022, 0.056, 0.118, 0.251 ul/ml with S9 - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: triethylenemelamine 0.5 ug/ml without S9, cyclophosphamide 50 ug/ml with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: 100 ul of dosing solutiong was added to the test medium
DURATION
- Preincubation period: 16-24 hrs at 37 degree C
- Exposure duration: 12 hrs without S9 at 37 degree in humidified air; 2 hrs with S9 at 37 degree in humidified air
- Expression time (cells in growth medium): For cells not treated with S9, two hours prior to cell harvest, treatment medium was removed and cells washed with PBS and refed with medium containing 0.1 ug/ml of Colcemid. For cells treated with S9, treatment medium was removed after exposure, cells were washed with PBS, refed, and returned to the incubator for 16 hrs. Colcemid was added at 0.1 ug/ml, and flasks incubated for two hrs.
- Fixation time (start of exposure up to fixation or harvest of cells): 14-20 hrs, collected by centrifugation
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays): 5% Giemsa
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 100 per concentration
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index and cell cycle delay
OTHER EXAMINATIONS:
Chromatid and isochromatid breaks, exchange figures, chromosome breaks, fragments, pulverized chromosomes, chromatid and isochromatid gaps
OTHER: - Evaluation criteria:
- In order for the test to be valid, there must be no more than 6% cells with chromosome aberrations in the negative and solvent control groups. Positive control must be statistically increased over untreated controls (p<=0.05, Fisher's exact test). A positive result is percentage of cells with aberrations was statistically increased over untreated controls (p<=0.05, Fisher's exact test).
- Statistics:
- Fisher's exact test was used to determine statistical significance. Cochran-Armitage test was used to test dose-responsiveness.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >= 0.074 ul/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity was observed at concentrations of 0.074 µL/mL or greater. No significant increase in chromosome aberrations was seen in treatment groups.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results: negative
The test substance is not clastogenic. - Executive summary:
This study examined the potential for commercial hexane to cause chromosome aberrations in Chinese Hamster Ovary (CHO) cells. CHO cells were exposed to concentrations of 0, 0.015, 0.034, 0.074, 0.123, and 0.416 µL/mL without metabolic activation and 0, 0.014, 0.022, 0.056, 0.118, and 0.251 µL/mL with metabolic activation. 0.5 µg/mL triethylenemelamine was used a positive control without metabolic activation and 50 µg/mL cyclophosphamide was used as a positive control with metabolic activation.
Negative and positive controls were valid. There was no significant increase in chromosome aberrations in any test group. The test substance was cytotoxic at concentrations of 0.074 µL/mL or greater. The test substance is not clastogenic.
Referenceopen allclose all
Average Revertants per Plate (SD) - Experiment B1
Dose (ppm) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
TA 1538 |
Without S9 |
|||||
0.0 |
17 ± 1 |
105 ± 12 |
11 ± 1 |
7 ± 1 |
8 |
600 |
20 ± 5 |
113 ± 9 |
13 ± 4 |
6 ± 1 |
6 |
1000 |
16 ± 3 |
121 ± 8 |
14 ± 2 |
7 ± 1 |
6 |
3000 |
18 ± 4 |
112 ± 13 |
17 ± 3 |
5 ± 4 |
4 |
6000 |
24 ± 4 |
117 ± 14 |
12 ± 4 |
6 ± 4 |
8 |
9000 |
17 ± 3 |
112 ± 7 |
14 ± 5 |
9 ± 2 |
5 |
Positive control |
227 ± 8 |
422 ± 44 |
349 ± 36 |
481 ± 135 |
452 |
With S9 |
|||||
0.0 |
24 ± 5 |
119 ± 10 |
17 ± 1 |
7 ± 0 |
12 |
600 |
30 ± 10 |
137 ± 12 |
23 ± 4 |
9 ± 4 |
15 |
1000 |
23 ± 5 |
126 ± 3 |
14 ± 2 |
11 ± 5 |
13 |
3000 |
22 ± 1 |
120 ± 19 |
16 ± 2 |
9 ± 2 |
9 |
6000 |
24 ± 2 |
103 ± 11 |
14 ± 4 |
7 ± 2 |
11 |
9000 |
30 ± 6 |
120 ± 3 |
17 ± 1 |
8 ± 2 |
14 |
Positive control |
3142 ± 139 |
3902 ± 68 |
189± 22 |
351 ± 26 |
-- |
Positive vapor control |
372 ± 52 |
Average Revertants per Plate (SD) - Experiment B2
Dose (ppm) |
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
TA 1538 |
Without S9 |
|||||
0.0 |
12 ± 2 |
107 ± 11 |
9 ± 5 |
5 ± 1 |
19 |
600 |
20 ± 1 |
103 ± 9 |
8 ± 4 |
7 ± 3 |
19 |
1000 |
14 ± 4 |
110 ± 6 |
12 ± 5 |
7 ± 2 |
19 |
3000 |
14 ± 1 |
124 ± 14 |
12 ± 2 |
7 ± 2 |
19 |
6000 |
22 ± 6 |
125 ± 14 |
15 ± 1 |
5 ± 2 |
16 |
9000 |
15 ± 6 |
114 ± 5 |
13 ± 3 |
5 ± 3 |
13 |
Positive control |
444 ± 86 |
991 ± 67 |
758 ± 19 |
162 ± 51 |
754 |
With S9 |
|||||
0.0 |
21 ± 4 |
132 ± 16 |
17 ± 4 |
7 ± 3 |
26 |
600 |
25 ± 7 |
133 ± 8 |
18 ± 2 |
6 ± 1 |
25 |
1000 |
22 ± 2 |
155 ± 4 |
15 ± 7 |
8 ± 3 |
25 |
3000 |
20 ± 1 |
123 ± 23 |
16 ± 7 |
7 ± 3 |
24 |
6000 |
21 ± 4 |
151 ± 14 |
15 ± 1 |
6 ± 2 |
30 |
9000 |
25 ± 4 |
161 ± 8 |
11 ± 4 |
6 ± 1 |
27 |
Positive control |
2187 ± 166 |
2229 ± 223 |
166 ± 32 |
230 ± 24 |
2195 |
Positive vapor control |
394 ± 50 |
In other experiments in vitro (with Escherichia coli, Bacillus subtilis, Salmonella typhimurium or Saccharomyces cerevisiae, as well as in the Chinese hamster cells) no genetic toxicity was found.
In the CHO-test sister chromatid exchange in the fraction with S9 -mix was reported, but no dose-response appeared.
CHO/HGPRT Mutation Assay
Dose (µl/ml) |
Total Colonies |
Cloning Efficiency |
Total Mutant Colonies |
Mutants/106 Clonable Cells |
Without S9 |
||||
Negative control |
310 |
1.03 |
19 |
18.4 |
Solvent Control |
329 |
1.10 |
6 |
5.5 |
0.132 |
284 |
0.95 |
0 |
5.3 |
0.098 |
260 |
0.87 |
0 |
5.8 |
0.063 |
321 |
1.07 |
0 |
0.9 |
0.0362 |
289 |
0.96 |
5 |
5.2 |
0.0122 |
294 |
0.98 |
12 |
12.2 |
Positive Control |
282 |
0.94 |
227 |
241.5 |
With S9 |
||||
Negative control |
320 |
1.07 |
0 |
0.9 |
Solvent Control |
330 |
1.10 |
1 |
0.9 |
0.132 |
299 |
1.00 |
0 |
1.0 |
0.098 |
299 |
0.99 |
0 |
1.0 |
0.063 |
256 |
0.85 |
4 |
4.7 |
0.0362 |
317 |
1.06 |
13 |
12.3 |
0.0122 |
293 |
0.98 |
13 |
13.3 |
Positive Control |
239 |
0.80 |
91 |
114.2 |
Results of CHO Chromosome Aberration Assay
Dose (µl/ml) |
Mitotic Index |
Cells Scored |
Aberrations per cell (mean ± SD) |
% Cells with Aberrations |
Without S9 |
||||
Negative Control |
5.7 |
100 |
0.010 ± 0.100 |
1 |
Solvent Control |
4.9 |
100 |
0.010 ± 0.100 |
1 |
0.015 |
4.8 |
100 |
0.000 ± 0.000 |
0 |
0.034 |
4.5 |
100 |
0.010 ± 0.100 |
1 |
0.074 |
2.9 |
100 |
0.010 ± 0.100 |
1 |
0.123 |
0.2 |
8 |
0.000 ± 0.000 |
0 |
0.416 |
0.0 |
0 |
||
Positive Control |
2.2 |
100 |
0.360 ± 1.124 |
21 |
With S9 |
||||
Negative Control |
5.3 |
100 |
0.010 ± 0.100 |
1 |
Solvent Control |
5.6 |
100 |
0.010 ± 0.100 |
1 |
0.014 |
5.3 |
100 |
0.010 ± 0.100 |
1 |
0.022 |
5.9 |
100 |
0.010 ± 0.100 |
1 |
0.056 |
3.1 |
100 |
0.010 ± 0.100 |
1 |
0.118 |
0.2 |
2 |
0.000 ± 0.000 |
0 |
0.251 |
0.0 |
0 |
||
Positive Control |
2.5 |
100 |
0.840 ± 1.819 |
40 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
There is no data available for Methylcyclopentane. Data is available from a structural analogue n-Hexane and used as read across.
In Vitro
The first in vitro study evaluated the mutagenicity of vapors of commercial hexane (52% n-hexane). According to the study report (API, 1989a; Klimisch score =1) plates of S. typhimurium were exposed for seven to eight hours to test atmospheres of 0, 600, 1000, 3000, 6000, or 9000 ppm of test substance. The test substance did not produce a positive response in any of the test strains.
In another bacterial reverse mutation assay (US DHHS, 1999), noin vitrotoxicity was found in assays using S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100 exposed to hexane at concentrations up to 1000 µg/plate in the presence and absence of metabolic activation.
Two in vitro studies determined the mutagenicity of commercial hexane (52% n-hexane) in Chinese hamster ovary (CHO) cells. In one
study CHO cells were exposed to concentrations of 0, 0.132, 0.098, 0.063, 0.0362, or 0.0122 µL/mL both with and without metabolic activation
for 5 hours (API, 1990d; Klimisch score =1). The cells were then analyzed for mutation frequency. The test substance was found not to be mutagenic both in the presence and absence of metabolic activation. However, the test substance was cytotoxic at concentrations of 0.063 µL/mL or greater.
In the second in vitro study CHO cells were exposed to concentrations of commercial hexane (52% n-hexane) of 0, 0.015, 0.034, 0.074,
0.123, and 0.416 µL/mL without metabolic activation and 0, 0.014, 0.022, 0.056, 0.118, and 0.251 µL/mL with metabolic activation (Daughtrey et al., 1984; Klimisch score = 1). 0.5 µg/mL triethylenemelamine was used a positive control without metabolic activation and 50 µg/mL cyclophosphamide was used as a positive control with metabolic activation. Negative and positive controls were found to be valid and no significant increase in chromosome aberrations were found. The test substance was however found to be cytotoxic at concentrations of 0.074 µL/mL or greater. The test substance is not clastogenic.
All studies were conducted in a manner similar or equivalent to currently established OECD guidelines.
Justification for classification or non-classification
There is no data available for Methylcyclopentane. Data is available from a structural analogue n-Hexane and used as read across.
Based on the negative results in the in vitro genotoxicity assays, Methylcyclopentane does not warrant classification for genetic toxicity under the new Regulation
(EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.